Study to Assess Compliance With Long-Term Mercaptopurine Treatment in Young Patients With Acute Lymphoblastic Leukemia in Remission

NCT00268528 · clinicaltrials.gov ↗

COMPLETED

Status

720

Enrollment

NETWORK

Sponsor class

Conditions

Childhood Acute Lymphoblastic Leukemia in Remission

Interventions

BEHAVIORAL: Compliance Monitoring
OTHER: Laboratory Biomarker Analysis
DRUG: Mercaptopurine
DRUG: Methotrexate
OTHER: Questionnaire Administration
OTHER: Study of Socioeconomic and Demographic Variables

Sponsor

Children's Oncology Group

Collaborators

[object Object]